Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | mitogen-activated protein kinase 14 | Starlite/ChEMBL | References |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Trypanosoma brucei | mitogen-activated protein kinase 5 | mitogen-activated protein kinase 14 | 360 aa | 336 aa | 33.3 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus granulosus | mitogen activated protein kinase 14 | 0.0152 | 0.9493 | 1 |
Echinococcus multilocularis | bromodomain adjacent to zinc finger domain | 0.0068 | 0.362 | 0.3814 |
Loa Loa (eye worm) | hypothetical protein | 0.002 | 0.02 | 0.02 |
Trypanosoma cruzi | ISWI complex protein | 0.0018 | 0.0059 | 0.0062 |
Loa Loa (eye worm) | hypothetical protein | 0.0044 | 0.191 | 0.191 |
Schistosoma mansoni | methyl-cpg binding protein mbd | 0.002 | 0.02 | 0.0511 |
Echinococcus multilocularis | tar DNA binding protein | 0.0072 | 0.3913 | 0.4122 |
Echinococcus multilocularis | mitogen activated protein kinase 11 | 0.0152 | 0.9493 | 1 |
Leishmania major | hypothetical protein, conserved | 0.0018 | 0.0059 | 0.0062 |
Loa Loa (eye worm) | bromodomain containing protein | 0.002 | 0.0249 | 0.0249 |
Schistosoma mansoni | zinc finger protein | 0.0022 | 0.0402 | 0.1028 |
Loa Loa (eye worm) | CMGC/MAPK/P38 protein kinase | 0.0152 | 0.9493 | 0.9493 |
Echinococcus multilocularis | histone lysine methyltransferase setb histone lysine methyltransferase eggless | 0.002 | 0.02 | 0.0211 |
Schistosoma mansoni | acetyl-CoA C-acetyltransferase | 0.0026 | 0.064 | 0.1637 |
Plasmodium vivax | isocitrate dehydrogenase [NADP], mitochondrial, putative | 0.0017 | 0 | 0.5 |
Brugia malayi | TAR-binding protein | 0.0072 | 0.3913 | 0.3913 |
Echinococcus multilocularis | methyl CpG binding domain protein 2 | 0.002 | 0.02 | 0.0211 |
Leishmania major | mitogen-activated protein kinase 3, putative,map kinase 3, putative | 0.0152 | 0.9493 | 1 |
Echinococcus granulosus | tar DNA binding protein | 0.0072 | 0.3913 | 0.4122 |
Echinococcus granulosus | zinc finger protein | 0.0022 | 0.0402 | 0.0424 |
Toxoplasma gondii | isocitrate dehydrogenase | 0.0017 | 0 | 0.5 |
Echinococcus multilocularis | mitogen activated protein kinase 11 | 0.0152 | 0.9493 | 1 |
Brugia malayi | Bromodomain containing protein | 0.0044 | 0.1904 | 0.1904 |
Loa Loa (eye worm) | hypothetical protein | 0.0049 | 0.2253 | 0.2253 |
Plasmodium falciparum | isocitrate dehydrogenase [NADP], mitochondrial | 0.0017 | 0 | 0.5 |
Echinococcus granulosus | methyl CpG binding domain protein 2 | 0.002 | 0.02 | 0.0211 |
Echinococcus multilocularis | zinc finger protein | 0.0022 | 0.0402 | 0.0424 |
Toxoplasma gondii | isocitrate dehydrogenase | 0.0017 | 0 | 0.5 |
Echinococcus multilocularis | bromodomain adjacent to zinc finger domain | 0.0041 | 0.1714 | 0.1806 |
Loa Loa (eye worm) | TAR-binding protein | 0.0072 | 0.3913 | 0.3913 |
Echinococcus granulosus | bromodomain adjacent to zinc finger domain | 0.0068 | 0.362 | 0.3814 |
Echinococcus granulosus | mitogen activated protein kinase 11 | 0.0152 | 0.9493 | 1 |
Schistosoma mansoni | tar DNA-binding protein | 0.0072 | 0.3913 | 1 |
Trypanosoma brucei | ISWI complex protein | 0.0018 | 0.0059 | 0.0062 |
Trypanosoma cruzi | mitogen-activated protein kinase 3, putative | 0.0152 | 0.9493 | 1 |
Schistosoma mansoni | tar DNA-binding protein | 0.0072 | 0.3913 | 1 |
Loa Loa (eye worm) | RNA binding protein | 0.0072 | 0.3913 | 0.3913 |
Mycobacterium tuberculosis | Probable isocitrate dehydrogenase [NADP] Icd1 (oxalosuccinate decarboxylase) (IDH) (NADP+-specific ICDH) (IDP) | 0.0017 | 0 | 0.5 |
Brugia malayi | RNA recognition motif domain containing protein | 0.0072 | 0.3913 | 0.3913 |
Schistosoma mansoni | hypothetical protein | 0.0018 | 0.0059 | 0.0152 |
Loa Loa (eye worm) | hypothetical protein | 0.0159 | 1 | 1 |
Schistosoma mansoni | bromodomain containing protein | 0.0072 | 0.3907 | 0.9987 |
Echinococcus granulosus | fetal alzheimer antigen falz | 0.0026 | 0.064 | 0.0675 |
Echinococcus multilocularis | mitogen activated protein kinase 14 | 0.0152 | 0.9493 | 1 |
Schistosoma mansoni | histone-lysine n-methyltransferase setb1 | 0.002 | 0.02 | 0.0511 |
Schistosoma mansoni | tar DNA-binding protein | 0.0072 | 0.3913 | 1 |
Echinococcus multilocularis | fetal alzheimer antigen, falz | 0.0026 | 0.064 | 0.0675 |
Trypanosoma brucei | mitogen-activated protein kinase 3, putative | 0.0152 | 0.9493 | 1 |
Brugia malayi | RNA binding protein | 0.0072 | 0.3913 | 0.3913 |
Loa Loa (eye worm) | RNA recognition domain-containing protein domain-containing protein | 0.0072 | 0.3913 | 0.3913 |
Loa Loa (eye worm) | hypothetical protein | 0.0047 | 0.2099 | 0.2099 |
Loa Loa (eye worm) | hypothetical protein | 0.0081 | 0.4504 | 0.4504 |
Schistosoma mansoni | tar DNA-binding protein | 0.0072 | 0.3913 | 1 |
Schistosoma mansoni | histone-lysine n-methyltransferase setb1 | 0.002 | 0.02 | 0.0511 |
Schistosoma mansoni | methyl-cpg binding protein mbd | 0.002 | 0.02 | 0.0511 |
Loa Loa (eye worm) | PHD-finger family protein | 0.0024 | 0.0487 | 0.0487 |
Brugia malayi | PHD-finger family protein | 0.0028 | 0.083 | 0.083 |
Trypanosoma cruzi | ISWI complex protein | 0.0018 | 0.0059 | 0.0062 |
Schistosoma mansoni | tar DNA-binding protein | 0.0072 | 0.3913 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0024 | 0.0487 | 0.1245 |
Echinococcus granulosus | bromodomain adjacent to zinc finger domain | 0.0041 | 0.1714 | 0.1806 |
Brugia malayi | Bromodomain containing protein | 0.0086 | 0.4847 | 0.4847 |
Echinococcus multilocularis | mitogen activated protein kinase 14 | 0.0152 | 0.9493 | 1 |
Schistosoma mansoni | zinc finger protein | 0.0018 | 0.0059 | 0.0152 |
Echinococcus granulosus | histone lysine methyltransferase setb | 0.002 | 0.02 | 0.0211 |
Brugia malayi | P38 map kinase family protein 2 | 0.0152 | 0.9493 | 0.9493 |
Trypanosoma cruzi | mitogen-activated protein kinase 3, putative | 0.0152 | 0.9493 | 1 |
Onchocerca volvulus | 0.0159 | 1 | 0.5 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.